MicroRNA-638 is highly expressed in human vascular smooth muscle cells and inhibits PDGF-BB-induced cell proliferation and migration through targeting orphan nuclear receptor NOR1

Cardiovascular Research

Volumn 99, Issue 1, 2013, Pages 185-193

  Li, Pan ^a,b   Liu, Yan ^b   Yi, Bing ^b   Wang, Guokun ^a   You, Xiaohua ^a   Zhao, Xianxian ^a   Summer, Ross ^b   Qin, Yongwen ^a   Sun, Jianxin ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Migration; miR 638; Orphan Nuclear Receptor NOR1; Proliferation; Vascular smooth muscle cell

Indexed keywords

ADENOVIRUS VECTOR; CYCLIN D1; MICRORNA; MICRORNA 638; ORPHAN NUCLEAR RECEPTOR; ORPHAN NUCLEAR RECEPTOR NOR1; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; GENE OVEREXPRESSION; GENE PRODUCT; GENE TARGETING; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA TRANSCRIPTION; UPREGULATION; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

MIGRATION; MIR-638; ORPHAN NUCLEAR RECEPTOR NOR1; PROLIFERATION; VASCULAR SMOOTH MUSCLE CELL;

CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PROTO-ONCOGENE PROTEINS C-SIS; RECEPTORS, STEROID; RECEPTORS, THYROID HORMONE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 84879379901     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvt082     Document Type: Article

References (45)

1. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:812-819 (Pubitemid 351544093)
2. Marx SO, Totary-Jain H, Marks AR. Vascular smooth muscle cell proliferation in restenosis. Circ Cardiovasc Interv 2011;4:104-111
3. Owens GK, Kumar MS,Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801 (Pubitemid 38823766)
4. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 2007;15:100-108 (Pubitemid 47253691)
5. Li L, Zhang HN, Chen HZ, Gao P, Zhu LH, Li HL et al. Sirt1 acts as a modulator of neointima formation following vascular injury in mice. Circ Res 2011;108:1180-1189
6. Millette E, Rauch BH, Kenagy RD, Daum G, Clowes AW. Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 2006;16:25-28 (Pubitemid 43012038)
7. Bayes-Genis A, Conover CA, Schwartz RS. The insulin-like growth factor axis: a review of atherosclerosis and restenosis. Circ Res 2000;86:125-130 (Pubitemid 30086171)
8. Raines EW. PDGF and cardiovascular disease. Cytokine Growth Factor Rev 2004;15: 237-254 (Pubitemid 38781049)
9. Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 2008;22:1276-1312 (Pubitemid 351717519)
10. Getachew R, Ballinger ML, Burch ML, Reid JJ, Khachigian LM, Wight TN et al. PDGF beta-receptor kinase activity and erk1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDL. Endocrinology 2010;151:4356-4367
11. Barst RJ. PDGF signaling in pulmonary arterial hypertension. J Clin Invest 2005;115: 2691-2694 (Pubitemid 41434394)
12. Hata A. Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol 2013;75:69-93
13. Kang H, Hata A. MicroRNA regulation of smooth muscle gene expression and phenotype. Curr Opin Hematol 2012;19:224-231
14. McDonald RA, Hata A, MacLean MR, Morrell NW, Baker AH. MicroRNA and vascular remodeling in acute vascular injury and pulmonary vascular remodeling. Cardiovasc Res 2012;93:594-604
15. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 2009;105:158-166
16. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. MiR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009;460: 705-710
17. Davis BN, Hilyard AC, Nguyen PH, Lagna G, Hata A. Induction of microRNA-221 by platelet-derived growth factor signaling is critical for modulation of vascular smooth muscle phenotype. J Biol Chem 2009;284:3728-3738
18. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009;104:476-487
19. Wang M, Li W, Chang GQ, Ye CS, Ou JS, Li XX et al. MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities. Arterioscler Thromb Vasc Biol 2011;31:2044-2053
20. Chan MC, Hilyard AC, Wu C, Davis BN, Hill NS, Lal A et al. Molecular basis for antagonism between PDGF and the TGFbeta family of signalling pathways by control of miR-24 expression. EMBO J 2010;29:559-573
21. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007;100:1579-1588 (Pubitemid 46897261)
22. Sun SG, Zheng B, Han M, Fang XM, Li HX, Miao SB et al. MiR-146a and kru?ppel-like factor 4 form a feedback loop to participate in vascular smooth muscle cell proliferation. Embo Rep 2011;12:56-62
23. Quintavalle M, Elia L, Condorelli G, Courtneidge SA. MicroRNA control of podosome formation in vascular smooth muscle cells in vivo and in vitro. J Cell Biol 2010;189:13-22
24. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 2009;23:2166-2178
25. Albinsson S, Suarez Y, Skoura A, Offermanns S, Miano JM, Sessa WC. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 2010;306:1118-1126
26. Bonta PI, Pols TW, de Vries CJ. NR4A nuclear receptors in atherosclerosis and veingraft disease. Trends Cardiovasc Med 2007;17:105-111 (Pubitemid 46518167)
27. Leeper NJ, Raiesdana A, Kojima Y, Chun HJ, Azuma J, Maegdefessel L et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011;226:1035-1043
28. Ni CW, Qiu H, Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol 2011; 300:H1762-H1769
29. Jung HJ, Coffinier C, Choe Y, Beigneux AP, Davies BS, Yang SH et al. Regulation of prelamin A but not lamin C by miR-9, a brain-specific microRNA. Proc Natl Acad Sci U S A 2012;109:E423-E431
30. You B, Jiang YY, Chen S, Yan G, Sun J. The orphan nuclear receptor nur77 suppresses endothelial cell activation through induction of ikappabalpha expression. Circ Res 2009;104:742-749
31. Lim HJ, Kang DH, Lim JM, Kang DM, Seong JK, Kang SW et al. Function of Ahnak protein in aortic smooth muscle cell migration through Rac activation. Cardiovasc Res 2013;97:302-310
32. Wang X, Cheng Y, Liu X, Yang J, Munoz D, Zhang C. Unexpected pro-injury effect of propofol on vascular smooth muscle cells with increased oxidative stress. Crit Care Med 2011;39:738-745
33. Castellot JJ Jr, Favreau LV, Karnovsky MJ, Rosenberg RD. Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase. J Biol Chem 1982;257:11 256-11 260 (Pubitemid 13203358)
34. Reilly CF, Fritze LM, Rosenberg RD. Heparin inhibition of smooth muscle cell proliferation: a cellular site of action. J Cell Physiol 1986;257:11-19 (Pubitemid 17178520)
35. Karpurapu M, Wang D, Van Quyen D, Kim TK, Kundumani-Sridharan V, Pulusani S et al. Cyclin d1 is a bona fide target gene of nfatc1 and is sufficient in the mediation of injury-induced vascular wall remodeling. J Biol Chem 2010;285:3510-3523
36. Marti'nez-Gonza'lez J, Rius J, Castelló A, Cases-Langhoff C, Badimon L. Neuronderived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation. Circ Res 2003;92:96-103 (Pubitemid 36105612)
37. Nomiyama T, Nakamachi T, Gizard F, Heywood EB, Jones KL, Ohkura N et al.. The NR4A orphan nuclear receptor nor1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J Biol Chem 2006;281: 33 467-33 476 (Pubitemid 46036728)
38. Li D,Wang Q, Liu C, Duan H, Zeng X, Zhang B et al. Aberrant expression of miR-638 contributes to benzo(a)pyrene-induced human cell transformation. Toxicol Sci 2012; 125:382-391
39. Yao Y, Suo AL, Li ZF, Liu LY, Tian T, Ni L et al. MicroRNA profiling of human gastric cancer. Mol Med Report 2009;2:963-970
40. Kahlert C, Klupp F, Brand K, Lasitschka F, Diederichs S, Kirchberg J et al. Invasion front-specific expression and prognostic significance of microRNA in colorectal liver metastases. Cancer Sci 2011;102:1799-1807
41. Lu J, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM et al. Glomerular and tubulointerstitial miR-638, miR-198 and miR-146a expression in lupus nephritis. Nephrology (Carlton) 2012;17:346-351
42. Liu X, Wang T, Wakita T, Yang W. Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus-infected human hepatoma cells. Virology 2010; 398:57-67
43. Arkenbout EK, de Waard V, van Bragt M, van Achterberg TA, Grimbergen JM, Pichon B et al. Protective function of transcription factor TR3 orphan receptor in atherogenesis: decreased lesion formation in carotid artery ligation model in TR3 transgenic mice. Circulation 2002;106:1530-1535
44. Martorell L, Martinez-Gonzalez J, Crespo J, Calvayrac O, Badimon L. Neuron-derived orphan receptor-1 (NOR-1) is induced by thrombin and mediates vascular endothelial cell growth. J Thromb Haemost 2007;5:1766-1773 (Pubitemid 47091422)
45. Zhao Y, Howatt DA, Gizard F, Nomiyama T, Findeisen HM, Heywood EB et al. Deficiency of the NR4A orphan nuclear receptor nor1 decreases monocyte adhesion and atherosclerosis. Circ Res 2010;107:501-511.